Methicillin-resistant Staphylococcus aureus and intercontinental travel--"bad bugs on the move!".

The pace at which newly emerging pathogens spread around the world has been greatly accelerated by intercontinental travel and migration. Every day, thousands of potentially infected human bodies interlink even the remotest parts of our world. As a consequence, the period during which new pathogens remain confined to the population from which they emerged is becoming ever shorter and their containment increasingly challenging. Against this background, there is high demand on the research community to respond to the microbiological aftermath of globalization and to provide knowledge for effective interventions. Although there is a long‐standing appreciation of the role of intercontinental travel in the pandemic spread of clinically overt infectious diseases,1 it was only recently that we learned about its contribution toward the “silent pandemic” of antimicrobial resistance.2 Extended‐spectrum β‐lactamase‐producing bacteria, for instance, use the commensal microflora of travelers to make their way around the globe.3 Obviously, our microbiome closely interacts with the environment at the destination and serves as a vehicle and reservoir for resistant bacteria. Recently, the discovery of New Delhi metallo‐β‐lactamase has drawn a lot of public attention to the link between travel and the global spread of bacterial multi‐resistance.4,5 Since then, the public fears and discussions largely circle around the threat of emerging multi‐resistance in gram‐negative bacteria. For several reasons, however, loss of effective antimicrobials against gram‐positive Staphylococcus aureus will remain high on the global health agenda. First, S. aureus spreads particularly well due to its capacity to persistently colonize the nose. From there, the organism is effectively shed onto the hands, into … Corresponding Author: PD Dr Philipp Zanger, MSc, Institute of Public Health, University of Heidelberg, Im Neuenheimer Feld 324, 69120 Heidelberg, Germany. E‐mail: philipp.zanger{at}uni-heidelberg.de

[1]  A. Wilder-Smith,et al.  The role of international travel in the spread of methicillin-resistant Staphylococcus aureus. , 2014, Journal of travel medicine.

[2]  A. Azhir,et al.  Antibiotics for methicillin-resistant Staphylococcus aureus skin and soft tissue infections: the challenge of outpatient therapy. , 2014, The American journal of emergency medicine.

[3]  L. Nilsson,et al.  Travel-associated faecal colonization with ESBL-producing Enterobacteriaceae: incidence and risk factors. , 2013, The Journal of antimicrobial chemotherapy.

[4]  C. Wolz,et al.  Import and spread of Panton-Valentine Leukocidin-positive Staphylococcus aureus through nasal carriage and skin infections in travelers returning from the tropics and subtropics. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  J. Otter,et al.  Community-associated meticillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated infection. , 2011, The Journal of hospital infection.

[6]  N. Woodford Unwanted souvenirs: travel and multi-resistant bacteria. , 2011, Journal of travel medicine.

[7]  E. Caumes,et al.  Transmission of Panton–Valentine leukocidin‐producing Staphylococcus aureus from returning travelers to household contacts , 2011, International journal of dermatology.

[8]  Sara E Cosgrove,et al.  Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  N. Woodford,et al.  Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study , 2010, The Lancet. Infectious diseases.

[10]  P. Zanger Staphylococcus aureus positive skin infections and international travel , 2010, Wiener klinische Wochenschrift.

[11]  M. Kalin,et al.  Imported Methicillin-Resistant Staphylococcus aureus, Sweden , 2010, Emerging infectious diseases.

[12]  Timothy R. Walsh,et al.  Characterization of a New Metallo-β-Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India , 2009, Antimicrobial Agents and Chemotherapy.

[13]  Henry F. Chambers,et al.  Waves of resistance: Staphylococcus aureus in the antibiotic era , 2009, Nature Reviews Microbiology.

[14]  E. Caumes,et al.  Skin and soft tissue infections in returning travelers. , 2009, The American journal of tropical medicine and hygiene.

[15]  W. Grander,et al.  The association between body-mass index and patient outcome in septic shock: a retrospective cohort study , 2009, Wiener klinische Wochenschrift.

[16]  D. J. Rogers,et al.  Global Transport Networks and Infectious Disease Spread , 2006, Advances in Parasitology.

[17]  James G. Johnson,et al.  Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  E. Caumes,et al.  Illnesses in travelers returning from the tropics: a prospective study of 622 patients. , 2006, Journal of travel medicine.